Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Colorescience Completes $15 Mil Stock Offering - Beauty Packaging
Beauty Industry, Mergers and Acquisitions

Colorescience Completes $15 Mil Stock Offering

The company announced the completion of its Series B round.

Colorescience – makers of the “all-on-one” makeup that combines makeup, skincare and sun care –   announced it has completed a $15 million Series B preferred stock offering.

And the price?  $1.14 per share, which is a 20% increase from its last round. The Series B round was lead by Longwood Fund with existing investors contributing $7.5 million.   

Mary Fisher, Chief Executive Officer of Colorescience, commented:

“We continue to be encouraged by the support of our Board and investors, and are very pleased to add a seasoned executive, Rich Aldrich of the Longwood Fund, to our Board of Directors.”
Aldrich has  co-founded and helped build several successful biotech companies, including Sirtris Pharmaceuticals (acquired by GlaxoSmithKline in 2008) and Concert Pharmaceuticals.

Add us as a preferred source on Google

Get the latest Beauty Packaging news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Beauty Packaging Newsletters